Riptide Bioscience, Inc.
Records under this name other than the patents Riptide Bioscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 1 of 1 · Back to Riptide Bioscience, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,016,480 | Peptide-Based Methods for Treating Pancreatic Cancer Lapsed on the fee record Ended Jul 10, 2026 · High confidence | Lapsed on the fee record | Ended Jul 10, 2026 | High confidence |